International Journal of Ophthalmic PathologyISSN: 2324-8599

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Micheal O Rourke

Royal Victoria Eye and Ear Hospital, Dublin, Ireland

Contact Micheal O Rourke


Michael has 20 years of global ophthalmic leadership experience across pharmaceuticals, drug delivery and medical devices.He was appointed President & CEO of GrayBug in 2013, a new ocular pharmaceutical and drug delivery company developing new therapeutics in w-AMD and glaucoma.Previous experience includes General Manager for Bausch + Lomb Pharmaceuticals, Chiron Vision Europe, Alza, Pfizer and 3M Pharma. Michael has managed 26 brands, led 13 product launches, and has been a team member in 19 device/drug approvals.He is Foundation Board Chairman for Lions Eye Institute, the world’s largest Eye Bank with a unique Ocular Research Center.

Research Interest

Ocular Immunology,Ocular Oncology


Relavant Topics